You have 9 free searches left this month | for more free features.

Condition

Esophagogastric Cancer (1)

Gastroesophageal Junction Adenocarcinoma (1)

Metastasis (1)

Oligometastatic Disease (1)

Pancreatic Cancer (1)

Surgery (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Massachusetts General Hospital (1)

University of Cologne (1)

Collaborator

Ipsen (1)

Servier (1)

Intervention

carboplatin (1)

folfox/ nal-iri (1)

nal-irinotecan (nal-iri) (onyvide), oxaliplatin (ox), 5-fluouracil (5-fu), folinic acid (fa) (1)

paclitaxel (1)

proton radiation therapy (1)

Study Documents

Intervention Type

drug (2)

radiation (1)

Funder Type

Other (2)

Study Type

Interventional (2)

NAPOX

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Gastroesophageal Junction Adenocarcinoma, Esophagogastric Cancer Trial in Boston, Newton (FOLFOX/ nal-IRI, Paclitaxel,

Not yet recruiting

Gastroesophageal Junction Adenocarcinoma
Esophagogastric Cancer

FOLFOX/ nal-IRI
+3 more

Boston, Massachusetts
+2 more

Nov 30, 2020

Pancreatic Cancer, Metastasis, Surgery Trial in Germany (nal-irinotecan (nal-iri) (Onyvide), oxaliplatin (ox), 5-fluouracil

Recruiting

Pancreatic Cancer
+3 more

nal-irinotecan (nal-iri) (Onyvide), oxaliplatin (ox), 5-fluouracil (5-FU), folinic acid (FA)

Aachen, Germany
+9 more

Feb 17, 2022